Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Kiniksa Pharmaceuticals (KNSA) Insider Trading & Ownership

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Free knsa Stock Alerts
$19.77
-0.34 (-1.69%)
(As of 05/17/2024 06:55 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
54.57%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.51 M

KNSA Insider Buying and Selling by Quarter

Ad Wall Street Star
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

Kiniksa Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/6/2024Sanj K PatelCEOSell5,582$21.00$117,222.00  
3/4/2024Sanj K PatelCEOSell12,742$21.49$273,825.58  
3/1/2024Michael R MegnaCAOSell9,659$21.45$207,185.55  
2/28/2024Michael R MegnaCAOSell5,126$21.79$111,695.54  
1/3/2024Mark RagosaCFOSell12,000$20.00$240,000.00  
1/2/2024Michael R MegnaCAOSell16,670$19.17$319,563.90  
Shocking: One AI startup's revenue could surge 4,735% (Ad)

Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.

Click here to discover the AI chip company
12/19/2023Michael R MegnaCAOSell9,316$19.13$178,215.08  
12/7/2023John F PaoliniInsiderSell28,600$17.65$504,790.00  
9/5/2023John F PaoliniInsiderSell400$17.53$7,012.00  
7/25/2023John F PaoliniInsiderSell29,000$19.14$555,060.00  
(Data available from 1/1/2013 forward)

KNSA Insider Trading Activity - Frequently Asked Questions

Who is on Kiniksa Pharmaceuticals's Insider Roster?

The list of insiders at Kiniksa Pharmaceuticals includes Barry D. Quart, John F Paolini, Mark Ragosa, Michael R Megna, and Sanj K Patel. Learn more on insiders at KNSA.

What percentage of Kiniksa Pharmaceuticals stock is owned by insiders?

54.57% of Kiniksa Pharmaceuticals stock is owned by insiders. Learn more on KNSA's insider holdings.

Which Kiniksa Pharmaceuticals insiders have been selling company stock?

The following insiders have sold KNSA shares in the last 24 months: Barry D. Quart ($354,637.85), John F Paolini ($1,066,862.00), Mark Ragosa ($240,000.00), Michael R Megna ($816,660.07), and Sanj K Patel ($391,047.58).

How much insider selling is happening at Kiniksa Pharmaceuticals?

Insiders have sold a total of 151,054 Kiniksa Pharmaceuticals shares in the last 24 months for a total of $2,869,207.50 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:KNSA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Urgent Nvidia Warning
Altimetry
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Bill Gates is all about this tiny $2 stock
Timothy Sykes
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Elon’s New Device is About to Shock the World
InvestorPlace